Any current/future new fundraising through debt or equity?

India Pesticides Limited currently maintains a strong balance sheet with low debt levels (total debt increased from INR 18 crore in FY '24 to INR 52 crore in FY '25, mainly short-term borrowings expected to normalize soon). The company is committed to funding all expansion and capital expenditure from internal accruals and maintaining a debt-free position. Planned capex of INR 116 crore for FY '26 is funded internally, with no mention of new fundraising through debt or equity. Management focus remains on operational growth and capacity expansion without plans for external fundraising. There wa

Any current/future capex/capital investment/strategic investment?

Planned Capex for FY '26: INR 116 crore for India Pesticides and its 100% subsidiary Shalvis Specialities Limited. Capex includes: - Expansion at Sandila site (INR 52 crore portion) for increasing capacity, adding a boiler, one intermediate, and one technical product complex. - New production blocks to manufacture new products not possible in existing blocks. Two-year targeted capex exceeds INR 200 crore. Hamirpur facility progressing well, expected to contribute to gradual revenue and profitability increase over coming years. Capex funded primarily through internal accruals, maintaining a

Future growth expectations in sales/revenue/volumes?

India Pesticides Limited projects a revenue of around INR 1,000 crores for FY '26, with capacity utilization currently at 61%, indicating room for scaling beyond this target if demand rises. The company anticipates a 15% to 20% CAGR revenue growth over the next 2-3 years, supported by capacity expansion and new product additions. Export contributions are expected to remain stable around 38-40% of total revenue, with focus on a balanced product mix catering to both domestic and international markets. Capacity expansions at Sandila and Hamirpur facilities will support growth, with peak revenues

Future growth expectations in earnings/operating earnings/profits/EPS?

India Pesticides Limited projects 15-20% revenue CAGR over the next 2-3 years driven by capacity expansions and new product additions. Revenue target for FY '26 is around INR 1,000 crores, with potential to scale up to INR 1,100 crores if demand exists. EBITDA margins expected to improve from current 16% to between 18% and 20% in FY '26 due to operating leverage, backward integration, and product mix optimization. Efforts ongoing to achieve even higher margins (~25%) over a few years through backward integration and process innovation. Strong growth in formulations (~20% CAGR) and bulk formula

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders by exact value. However, management indicates an optimistic outlook on order inflows: - They have started receiving orders for products registered in the U.S. and Europe and expect these to grow in the coming months. - Supply to Japanese collaborators has commenced with expectations of increasing volume significantly next year. - Export demand is picking up steadily following stabilization of supply and prices post-COVID and Chinese destocking. - They are actively adding new products every y

India Pesticides LtdQ1 FY26

India Pesticides Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹141P/E: 15.6Market Cap: ₹1.7K Cr

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→India Pesticides Limited projects a revenue of around INR 1,000 crores for FY '26, with capacity utilization currently at 61%, indicating room for scaling beyond this target if demand rises.
→The company anticipates a 15% to 20% CAGR revenue growth over the next 2-3 years, supported by capacity expansion and new product additions.
→Export contributions are expected to remain stable around 38-40% of total revenue, with focus on a balanced product mix catering to both domestic and international markets.
→Capacity expansions at Sandila and Hamirpur facilities will support growth, with peak revenues estimated around INR 1,100 crores from Sandila alone.
→Growth drivers include backward integration, new product registrations in regulated markets (EU, USA, Australia), and increased formulations business, especially bulk formulations exports showing over 20% YoY growth.
→Continuously expanding distribution network in India and improving demand from regulated export markets will fuel volume growth.

Margin guidance

Category 1

→India Pesticides Limited projects 15-20% revenue CAGR over the next 2-3 years driven by capacity expansions and new product additions.
→Revenue target for FY '26 is around INR 1,000 crores, with potential to scale up to INR 1,100 crores if demand exists.
→EBITDA margins expected to improve from current 16% to between 18% and 20% in FY '26 due to operating leverage, backward integration, and product mix optimization.
→Efforts ongoing to achieve even higher margins (~25%) over a few years through backward integration and process innovation.
→Strong growth in formulations (~20% CAGR) and bulk formulations exports contributing to revenue and profitability.
→Expansion of presence in regulated markets (EU, USA, Australia) anticipated to drive incremental revenue growth.
→Capex of INR 116 crore planned for FY '26 to enhance capacity and production capabilities, funded largely through internal accruals.
→Earnings growth supported by stable prices, improved demand, and reduction in raw material cost pressures.

3 more insights locked — sign up free to unlock

Fundraise plans

→India Pesticides Limited currently maintains a strong balance sheet with low debt levels (total debt increased from INR 18 crore in FY '24 to INR 52 crore in FY '25, mainly short-term borrowings expected to normalize soon).
→The company is committed to funding all expansion and capital expenditure from internal accruals and maintaining a debt-free position.
→Planned capex of INR 116 crore for FY '26 is funded internally, with no mention of new fundraising through debt or equity.
→Management focus remains on operational growth and capacity expansion without plans for external fundraising.
→There was no indication or discussion about imminent equity fundraising or debt issuance during the call.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders by exact value.
→However, management indicates an optimistic outlook on order inflows:
→ - They have started receiving orders for products registered in the U.S. and Europe and expect these to grow in the coming months.
→ - Supply to Japanese collaborators has commenced with expectations of increasing volume significantly next year.
→ - Export demand is picking up steadily following stabilization of supply and prices post-COVID and Chinese destocking.
→ - They are actively adding new products every year to their portfolio, contributing to incremental revenue growth.
→Capacity utilization is currently around 61%, with plans to increase production capacity by adding new blocks.
→Overall, the company is optimistic about scaling revenues to INR 1,000-1,100 crores in FY '26 on existing capacity and expected demand.

Capex plans

Yes

→Planned Capex for FY '26: INR 116 crore for India Pesticides and its 100% subsidiary Shalvis Specialities Limited.
→Capex includes:
→ - Expansion at Sandila site (INR 52 crore portion) for increasing capacity, adding a boiler, one intermediate, and one technical product complex.
→ - New production blocks to manufacture new products not possible in existing blocks.
→Two-year targeted capex exceeds INR 200 crore.
→Hamirpur facility progressing well, expected to contribute to gradual revenue and profitability increase over coming years.
→Capex funded primarily through internal accruals, maintaining a debt-free position.
→Strategic efforts include backward integration to improve margins, ramping up production, and diversifying product portfolio.
→Exploration under CRDMO initiative to collaborate with international companies for scaling research products commercially.

How does India Pesticides Ltd rank vs peers in ?

Pro feature

1India Pesticides Ltd

Rev 3Mar 1

See full sector rankings

Want more stocks like India Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio